# Simplified Dual Regimen Guided by Fecal Clarithromycin Resistance Gene Detection for First-line H. Pylori Eradication

> **NCT07439445** · NA · RECRUITING · sponsor: **Peking University First Hospital** · enrollment: 70 (estimated)

## Conditions studied

- Helicobacter Pylori Infection

## Interventions

- **DRUG:** Vonoprazan 20 mg twice daily + clarithromycin 500 mg twice daily for 14 days

## Key facts

- **NCT ID:** NCT07439445
- **Lead sponsor:** Peking University First Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2026-04-25
- **Primary completion:** 2027-02-13
- **Final completion:** 2027-02-13
- **Target enrollment:** 70 (ESTIMATED)
- **Last updated:** 2026-04-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07439445

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07439445, "Simplified Dual Regimen Guided by Fecal Clarithromycin Resistance Gene Detection for First-line H. Pylori Eradication". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT07439445. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*